Lipopolysaccharide regulation of intestinal tight junction permeability is mediated by TLR4 signal transduction pathway activation of FAK and MyD88

Journal of Immunology

Volumn 195, Issue 10, 2015, Pages 4999-5010

  Guo, Shuhong ^a,b   Nighot, Meghali ^a   Al Sadi, Rana ^a,b   Alhmoud, Tarik ^a   Nighot, Prashant ^a   Ma, Thomas Y ^a,b  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b VA Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOCAL ADHESION KINASE; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; LIPOPOLYSACCHARIDE; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 4; FOCAL ADHESION KINASE 1; MYD88 PROTEIN, HUMAN; MYD88 PROTEIN, MOUSE; PTK2 PROTEIN, HUMAN; PTK2 PROTEIN, MOUSE; TLR4 PROTEIN, HUMAN; TLR4 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; ENZYME ACTIVITY; GENE SILENCING; IMMUNOMODULATION; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; INTESTINE MUCOSA PERMEABILITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN POLYMORPHISM; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TIGHT JUNCTION; TRANSCRIPTION REGULATION; ANIMAL; CACO-2 CELL LINE; DRUG EFFECTS; ENZYME ACTIVATION; GENETICS; HUMAN; IMMUNOLOGY; INTESTINE; KNOCKOUT MOUSE; PERMEABILITY;

ANIMALS; CACO-2 CELLS; ENZYME ACTIVATION; FOCAL ADHESION KINASE 1; HUMANS; INTESTINES; LIPOPOLYSACCHARIDES; MICE; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; PERMEABILITY; SIGNAL TRANSDUCTION; TIGHT JUNCTIONS; TOLL-LIKE RECEPTOR 4;

EID: 84952682341     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402598     Document Type: Article

References (44)

1. Turner, J. R. 2009. Intestinal mucosal barrier function in health and disease. Nat. Rev. Immunol. 9: 799-809.
2. Ma, T. Y., and J. M. Anderson. 2006. Tight junctions and the intestinal barrier. In Physiology of the Gastrointestinal Tract. L. R. Johnson, K. E. Barrett, F. K. Ghishan, J. L. Merchant, H. M. Said, and J. D. Wood, eds. Elsevier Academic Press, Burlington, MA, p. 1559-1594.
3. Berman, L., and R. L. Moss. 2011. Necrotizing enterocolitis: an update. Semin. Fetal Neonatal Med. 16: 145-150.
4. Clark, J. A., S. M. Doelle, M. D. Halpern, T. A. Saunders, H. Holubec, K. Dvorak, S. A. Boitano, and B. Dvorak. 2006. Intestinal barrier failure during experimental necrotizing enterocolitis: protective effect of EGF treatment. Am. J. Physiol. Gastrointest. Liver Physiol. 291: G938-G949.
5. Oriishi, T., M. Sata, A. Toyonaga, E. Sasaki, and K. Tanikawa. 1995. Evaluation of intestinal permeability in patients with inflammatory bowel disease using lactulose and measuring antibodies to lipid A. Gut 36: 891-896.
6. Munkholm, P., E. Langholz, D. Hollander, K. Thornberg, M. Orholm, K. D. Katz, and V. Binder. 1994. Intestinal permeability in patients with Crohn's disease and ulcerative colitis and their first degree relatives. Gut 35: 68-72.
7. Arrieta, M. C., K. Madsen, J. Doyle, and J. Meddings. 2009. Reducing small intestinal permeability attenuates colitis in the IL10 gene-deficient mouse. Gut 58: 41-48.
8. Mennigen, R., K. Nolte, E. Rijcken, M. Utech, B. Loeffler, N. Senninger, and M. Bruewer. 2009. Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 296: G1140-G1149.
9. Benoit, R., S. Rowe, S. C. Watkins, P. Boyle, M. Garrett, S. Alber, J. Wiener, M. I. Rowe, and H. R. Ford. 1998. Pure endotoxin does not pass across the intestinal epithelium in vitro. Shock 10: 43-48.
10. Ge, Y., R. M. Ezzell, and H. S. Warren. 2000. Localization of endotoxin in the rat intestinal epithelium. J. Infect. Dis. 182: 873-881.
11. Hurley, J. C. 1995. Endotoxemia: methods of detection and clinical correlates. Clin. Microbiol. Rev. 8: 268-292.
12. Andreasen, A. S., K. S. Krabbe, R. Krogh-Madsen, S. Taudorf, B. K. Pedersen, and K. Muller. 2008. Human endotoxemia as a model of systemic inflammation. Curr. Med. Chem. 15: 1697-1705.
13. Marshall, J. C., P. M. Walker, D. M. Foster, D. Harris, M. Ribeiro, J. Paice, A. D. Romaschin, and A. N. Derzko. 2002. Measurement of endotoxin activity in critically ill patients using whole blood neutrophil dependent chemiluminescence. Crit. Care 6: 342-348.
14. Wellmann, W., P. C. Fink, F. Benner, and F. W. Schmidt. 1986. Endotoxaemia in active Crohn's disease. Treatment with whole gut irrigation and 5-aminosalicylic acid. Gut 27: 814-820.
15. Sharma, R., J. J. Tepas, III, M. L. Hudak, D. L. Mollitt, P. S. Wludyka, R. J. Teng, and B. R. Premachandra. 2007. Neonatal gut barrier and multiple organ failure: role of endotoxin and proinflammatory cytokines in sepsis and necrotizing enterocolitis. J. Pediatr. Surg. 42: 454-461.
16. Leal, R. F., M. Milanski, Mde. L. Ayrizono, A. Coope, V. S. Rodrigues, M. Portovedo, L. M. Oliveira, J. J. Fagundes, C. S. Coy, and L. A. Velloso. 2013. Toll-like receptor 4, F4/80 and pro-inflammatory cytokines in intestinal and mesenteric fat tissue of Crohn's disease. Int. J. Clin. Exp. Med. 6: 98-104.
17. Le Mandat Schultz, A., A. Bonnard, F. Barreau, Y. Aigrain, C. Pierre-Louis, D. Berrebi, and M. Peuchmaur. 2007. Expression of TLR-2, TLR-4, NOD2 and pNF-kappaB in a neonatal rat model of necrotizing enterocolitis. PLoS One 2: e1102.
18. De Jager, P. L., D. Franchimont, A. Waliszewska, A. Bitton, A. Cohen, D. Langelier, J. Belaiche, S. Vermeire, L. Farwell, A. Goris, et al; Quebec IBD Genetics Consortium; NIDDK IBD Genetics Consortium. 2007. The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases. Genes Immun. 8: 387-397.
19. Yu, L. C., A. N. Flynn, J. R. Turner, and A. G. Buret. 2005. SGLT-1-mediated glucose uptake protects intestinal epithelial cells against LPS-induced apoptosis and barrier defects: a novel cellular rescue mechanism? FASEB J. 19: 1822-1835.
20. Hirotani, Y., K. Ikeda, R. Kato, M. Myotoku, T. Umeda, Y. Ijiri, and K. Tanaka. 2008. Protective effects of lactoferrin against intestinal mucosal damage induced by lipopolysaccharide in human intestinal Caco-2 cells. Yakugaku Zasshi 128: 1363-1368.
21. Guo, S., R. Al-Sadi, H. M. Said, and T. Y. Ma. 2013. Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro and in vivo by inducing enterocyte membrane expression and localization of TLR-4 and CD14. Am. J. Pathol. 182: 375-387.
22. Lu, Y. C., W. C. Yeh, and P. S. Ohashi. 2008. LPS/TLR4 signal transduction pathway. Cytokine 42: 145-151.
23. Xu, B., G. Song, and Y. Ju. 2011. Effect of focal adhesion kinase on the regulation of realignment and tenogenic differentiation of human mesenchymal stem cells by mechanical stretch. Connect. Tissue Res. 52: 373-379.
24. Zeisel, M. B., V. A. Druet, J. Sibilia, J. P. Klein, V. Quesniaux, and D. Wachsmann. 2005. Cross talk between MyD88 and focal adhesion kinase pathways. J. Immunol. 174: 7393-7397.
25. Ye, D., S. Guo, R. Al-Sadi, and T. Y. Ma. 2011. MicroRNA regulation of intestinal epithelial tight junction permeability. Gastroenterology 141: 1323-1333.
26. Al-Sadi, R., K. Khatib, S. Guo, D. Ye, M. Youssef, and T. Ma. 2011. Occludin regulates macromolecule flux across the intestinal epithelial tight junction barrier. Am. J. Physiol. Gastrointest. Liver Physiol. 300: G1054-G1064.
27. Chen, H. C., P. A. Appeddu, H. Isoda, and J. L. Guan. 1996. Phosphorylation of tyrosine 397 in focal adhesion kinase is required for binding phosphatidylinositol 3-kinase. J. Biol. Chem. 271: 26329-26334.
28. Etienne, S., P. Adamson, J. Greenwood, A. D. Strosberg, S. Cazaubon, and P. O. Couraud. 1998. ICAM-1 signaling pathways associated with Rho activation in microvascular brain endothelial cells. J. Immunol. 161: 5755-5761.
29. Liu, C., A. Li, Y. B. Weng, M. L. Duan, B. E. Wang, and S. W. Zhang. 2009. Changes in intestinal mucosal immune barrier in rats with endotoxemia. World J. Gastroenterol. 15: 5843-5850.
30. Huber, N. L., S. R. Bailey, R. M. Schuster, C. K. Ogle, A. B. Lentsch, and T. A. Pritts. 2010. Remote thermal injury increases LPS-induced intestinal IL-6 production. J. Surg. Res. 160: 190-195.
31. Tomita, M., R. Ohkubo, and M. Hayashi. 2004. Lipopolysaccharide transport system across colonic epithelial cells in normal and infective rat. Drug Metab. Pharmacokinet. 19: 33-40.
32. Buchholz, B. M., R. S. Chanthaphavong, and A. J. Bauer. 2009. Nonhemopoietic cell TLR4 signaling is critical in causing early lipopolysaccharide-induced ileus. J. Immunol. 183: 6744-6753.
33. Aoshiba, K., S. Onizawa, T. Tsuji, and A. Nagai. 2009. Therapeutic effects of erythropoietin in murine models of endotoxin shock. Crit. Care Med. 37: 889-898.
34. Wirtz, S., C. Neufert, B. Weigmann, and M. F. Neurath. 2007. Chemically induced mouse models of intestinal inflammation. Nat. Protoc. 2: 541-546.
35. Sukhotnik, I., J. Mogilner, M. M. Krausz, M. Lurie, M. Hirsh, A. G. Coran, and E. Shiloni. 2004. Oral arginine reduces gut mucosal injury caused by lipopolysaccharide endotoxemia in rat. J. Surg. Res. 122: 256-262.
36. Wright, S. D., P. S. Tobias, R. J. Ulevitch, and R. A. Ramos. 1989. Lipopolysaccharide (LPS) binding protein opsonizes LPS-bearing particles for recognition by a novel receptor on macrophages. J. Exp. Med. 170: 1231-1241.
37. Wright, S. D., R. A. Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249: 1431-1433.
38. Shimazu, R., S. Akashi, H. Ogata, Y. Nagai, K. Fukudome, K. Miyake, and M. Kimoto. 1999. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189: 1777-1782.
39. O'Neill, L. A., and A. G. Bowie. 2007. The family of five: TIR-domaincontaining adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 7: 353-364.
40. Parsons, J. T. 2003. Focal adhesion kinase: the first ten years. J. Cell Sci. 116: 1409-1416.
41. Leaphart, C. L., J. Cavallo, S. C. Gribar, S. Cetin, J. Li, M. F. Branca, T. D. Dubowski, C. P. Sodhi, and D. J. Hackam. 2007. A critical role for TLR4 in the pathogenesis of necrotizing enterocolitis by modulating intestinal injury and repair. J. Immunol. 179: 4808-4820.
42. Petzold, T., A.W. Orr, C. Hahn, K. A. Jhaveri, J. T. Parsons, and M. A. Schwartz. 2009. Focal adhesion kinase modulates activation of NF-kappaB by flow in endothelial cells. Am. J. Physiol. Cell Physiol. 297: C814-C822.
43. Suzuki, N., S. Suzuki, G. S. Duncan, D. G. Millar, T. Wada, C. Mirtsos, H. Takada, A. Wakeham, A. Itie, S. Li, et al. 2002. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature 416: 750-756.
44. Cheng, H., T. Addona, H. Keshishian, E. Dahlstrand, C. Lu, M. Dorsch, Z. Li, A. Wang, T. D. Ocain, P. Li, et al. 2007. Regulation of IRAK-4 kinase activity via autophosphorylation within its activation loop. Biochem. Biophys. Res. Commun. 352: 609-616.